PROCEPT BioRobotics Corporation (PRCT)
NASDAQ: PRCT · Real-Time Price · USD
17.91
+0.40 (2.28%)
At close: Oct 7, 2026, 4:00 PM EDT
17.74
-0.17 (-0.95%)
Pre-market: Oct 8, 2026, 4:16 AM EDT
PROCEPT BioRobotics Revenue
PROCEPT BioRobotics had revenue of $94.50M in the quarter ending June 30, 2026, with 19.34% growth. This brings the company's revenue in the last twelve months to $337.34M, up 22.69% year-over-year. In the year 2025, PROCEPT BioRobotics had annual revenue of $308.05M with 37.22% growth. That makes PROCEPT BioRobotics the 13,666th largest company in the world by revenue and 2,544th in the United States.
Revenue (ttm)
$337.34M
Revenue Growth
+22.69%
P/S Ratio
3.04
Revenue / Employee
$379,889
Employees
888
Market Cap
1.03B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 308.05M | 83.56M | 37.22% |
| Dec 31, 2024 | 224.50M | 88.31M | 64.84% |
| Dec 31, 2023 | 136.19M | 61.18M | 81.55% |
| Dec 31, 2022 | 75.01M | 40.54M | 117.60% |
| Dec 31, 2021 | 34.47M | 26.76M | 346.72% |
| Dec 31, 2020 | 7.72M | 1.55M | 25.09% |
| Dec 31, 2019 | 6.17M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Enovis | 2.30B |
| Integra LifeSciences Holdings | 1.65B |
| Lumexa Imaging Holdings | 1.04B |
| Tandem Diabetes Care | 1.04B |
| Bioventus | 581.85M |
| Artivion | 471.47M |
| SI-BONE | 213.60M |
| Pacific Biosciences of California | 159.27M |
PRCT News
- 1 day ago - Procept BioRobotics initiated with an Overweight at Barclays - TheFly
- 16 days ago - Kaplan Fox Encourages PROCEPT BioRobotics Corporation (NASDAQ: PRCT) Investors Seeking Recovery to Contact the Firm Before September 22, 2026 - GlobeNewsWire
- 16 days ago - Long-Term Shareholders of PROCEPT BioRobotics Corporation (PRCT) Are Encouraged to Contact Johnson Fistel Regarding Potential Claims - GlobeNewsWire
- 21 days ago - Kaplan Fox Reminds PROCEPT BioRobotics Corporation (PRCT) Investors That They Have Until September 22, 2026 to Move for Lead Plaintiff - Newsfile Corp
- 22 days ago - PROCEPT BioRobotics Transcript: 2026 Global Healthcare Conference - Transcripts
- 22 days ago - LAWSUIT NOTICE: NASDAQ: PRCT Investors who lost money with PROCEPT BioRobotics Corporation shares should contact the Shareholders Foundation - PRNewsWire
- 23 days ago - Kaplan Fox & Kilsheimer LLP Alerts PROCEPT BioRobotics Corporation (PRCT) Investors to Their Right to Seek Lead Plaintiff Status Before September 22, 2026 - Newsfile Corp
- 27 days ago - Kaplan Fox & Kilsheimer LLP Encourages Investors of PROCEPT BioRobotics Corporation (PRCT) to Contact the Firm Ahead of the Lead Plaintiff Deadline on September 22, 2026 - Newsfile Corp